PAR 5.13% 20.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2645

  1. 9,938 Posts.
    lightbulb Created with Sketch. 227
    So I emailed the Perth team asking WTH is going on with their timeframes as I am still waiting, the reply is below:

    "Thank you for your email and your interest in the study.
    Due to the current COVID situation, the study is on hold at Linear.
    We will keep you posted as soon as we have a timeframe for the study."

    Short and sweet, and not good to hear IMO - should the company not be announcing these delays?

    Cheers and GLTA

    Cabe
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.